2008
DOI: 10.1517/14656566.9.2.243
|View full text |Cite
|
Sign up to set email alerts
|

Treatment strategies for endometriosis

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

0
39
0
2

Year Published

2008
2008
2023
2023

Publication Types

Select...
7
2
1

Relationship

0
10

Authors

Journals

citations
Cited by 67 publications
(41 citation statements)
references
References 81 publications
0
39
0
2
Order By: Relevance
“…Decreasing or eliminating the menstrual cycle (and tubaric reflux as a result) through the use of cyclic or continuous OCs may reduce the probability of cyst recurrence or peritoneal reimplantation [5]. The efficacy of postoperative OCs treatment is also supported by the theory that anovulation and moderately low oestrogen concentration may induce atrophy of the endometriotic implants [32], reduce disease-related pain [16], down-regulate cell proliferation and enhance programmed cell death (apoptosis) in the endometrium, which is abnormally low in women with endometriosis [33].…”
Section: Discussionmentioning
confidence: 99%
“…Decreasing or eliminating the menstrual cycle (and tubaric reflux as a result) through the use of cyclic or continuous OCs may reduce the probability of cyst recurrence or peritoneal reimplantation [5]. The efficacy of postoperative OCs treatment is also supported by the theory that anovulation and moderately low oestrogen concentration may induce atrophy of the endometriotic implants [32], reduce disease-related pain [16], down-regulate cell proliferation and enhance programmed cell death (apoptosis) in the endometrium, which is abnormally low in women with endometriosis [33].…”
Section: Discussionmentioning
confidence: 99%
“…Progestagens, natural or synthetic steroid hormones that produce effects similar to progesterone (P4), are used in hormone therapy to counteract estrogen-induced proliferation of the endometrium (Rodgers and Falcone 2008). Aside from their local action, progestagens act at different body sites, including central nervous system (CNS) structures such as the prefrontal cortex, hippocampus, amygdala, and hypothalamus.…”
mentioning
confidence: 99%
“…GnRHa and GnRH antagonists use results in a hypo estrogenic state with hot flushes and bone loss, which limits the treatment duration. Progestins, the other therapeutic option, can induce bloating, breakthrough bleeding, mood changes, acne, hirsutism that can alter therapeutic compliance [73].…”
Section: Treatment Of Endometriosismentioning
confidence: 99%